Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery

NCT00917254 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

369

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: YM150
DRUG: Placebo
DRUG: Enoxaparin

Sponsor

Astellas Pharma Inc